首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

CELLULAR ONCOLOGY
ISSN：2211-3428

CELLULAR ONCOLOGY

CELL ONCOL
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：平均12月
新锐分区：医学2区
年发文量：116
影响因子：4.8
JCR分区：Q1

基本信息

国际细胞肿瘤学会官方期刊专注于转化研究解决细胞生物学向临床应用的转化细胞肿瘤学发表来自不同生物医学和临床学科的科学论文，涉及细胞和组织水平的基础和转化癌症研究、该领域的技术和生物信息学发展以及临床应用。这包括许多领域，如基因组技术、微阵列和其他高通量技术、基因组不稳定性、SNP、DNA甲基化、信号通路、DNA组织、（亚）显微成像、蛋白质组学、生物信息学、基因组学的功能效应、药物设计和开发、分子诊断和靶向癌症治疗、基因型-表型相互作用。一个主要目标是将这些领域的最新发展从研究实验室转化为常规患者管理。为此，细胞肿瘤学在分子生物学家、遗传学家、技术开发人员、病理学家、（医学）肿瘤学家和其他参与癌症患者管理的临床医生之间形成了一个科学信息交流的平台。体外研究优先得到具有临床病理学相关性的肿瘤组织验证的支持。
2211-3428SCIE/Scopus收录/DOAJ开放期刊
4.8
点击查看最新影响趋势>
5.3
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
3区
CELL BIOLOGY 细胞生物学
3区
PATHOLOGY 病理学
2区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：CELL BIOLOGY
SCIE
Q2
66/204
学科：ONCOLOGY
SCIE
Q1
75/328
学科：PATHOLOGY
SCIE
Q1
9/90
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：CELL BIOLOGY
SCIE
Q1
45/204
学科：ONCOLOGY
SCIE
Q1
60/328
学科：PATHOLOGY
SCIE
Q1
17/90
31
116
点击查看年发文量趋势图>
23%约25%平均12月-ONCOLOGY-CELL BIOLOGY
0%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
78.45%32.5%2.2%
CiteScore：8.30
SJR：1.573
SNIP：0.888
学科类别分区排名百分位
大类：Medicine
小类：Oncology
Q1
74 / 415
大类：Medicine
小类：Molecular Medicine
Q1
42 / 177
大类：Medicine
小类：Cancer Research
Q2
64 / 233

期刊高被引文献

Tumor-associated macrophages: role in cancer development and therapeutic implications
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00453-z
Leptin-induced signaling pathways in cancer cell migration and invasion
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00428-0
The emerging role of noncoding RNAs in colorectal cancer chemoresistance
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00466-8
Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00476-6
Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00429-z
SNHG6 is upregulated in primary breast cancers and promotes cell cycle progression in breast cancer-derived cell lines
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00422-6
Curcumin: a potent agent to reverse epithelial-to-mesenchymal transition
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00442-2
Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00441-3
Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer - a short report
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00438-y
Esophageal carcinoma: Towards targeted therapies
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00488-2
CD47: role in the immune system and application to cancer therapy
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00469-5
The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00459-7
Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00455-x
Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00450-2
A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00478-4
Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00461-z
Deep learning and manual assessment show that the absolute mitotic count does not contain prognostic information in triple negative breast cancer
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00445-z
Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00467-7
Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00440-4
Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00446-y
HMGB1: an overview of its versatile roles in the pathogenesis of colorectal cancer
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00477-5
Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00471-x
CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00434-2
Recombinant cell-permeable HOXA9 protein inhibits NSCLC cell migration and invasion
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00424-4
The role of caveolin-1 in tumors of the brain - functional and clinical implications
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00447-x
Molecular profiling of anastatic cancer cells: potential role of the nuclear export pathway
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00451-1
Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00452-0
PRMT1 promotes pancreatic cancer growth and predicts poor prognosis
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00435-1
Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00487-3
MicroRNA-129-5p suppresses nasopharyngeal carcinoma lymphangiogenesis and lymph node metastasis by targeting ZIC2
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00485-5
Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00432-4
Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00470-y
The role of TNF-α in chordoma progression and inflammatory pathways
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00454-y
Mechanism of lung adenocarcinoma spine metastasis induced by CXCL17
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00491-7
Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00444-0
Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00475-7
The Xc− inhibitor sulfasalazine improves the anti-cancer effect of pharmacological vitamin C in prostate cancer cells via a glutathione-dependent mechanism
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00474-8
CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00479-3
ABT-263 exhibits apoptosis-inducing potential in oral cancer cells by targeting C/EBP-homologous protein
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00431-5
Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00425-3
Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00473-9
Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content – a short report
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00436-0
Endocrine resistant breast cancer cells with loss of ERα expression retain proliferative ability by reducing caspase7-mediated HDAC3 cleavage
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00439-x
Author Correction: PRMT1 promotes pancreatic cancer growth and predicts poor prognosis
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00480-w
Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00468-6
Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00423-5
The X-linked inhibitor of apoptosis protein (XIAP) is involved in melanoma invasion by regulating cell migration and survival
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00427-1
Stromal organization as predictive biomarker for the treatment of colon cancer with adjuvant bevacizumab; a post-hoc analysis of the AVANT trial
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00449-9
Author Correction: The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00483-7
The tumor suppressor FOXO3a mediates the response to EGFR inhibition in glioblastoma cells
来源期刊：Cellular OncologyDOI：10.1007/s13402-019-00443-1

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACADEMIC EMERGENCY MEDICINE封面

ACADEMIC EMERGENCY MEDICINE

学科领域：医学
影响因子：3.2
中科院分区： 2区
ACADEMIC RADIOLOGY封面

ACADEMIC RADIOLOGY

学科领域：医学
影响因子：3.9
中科院分区： 2区
APPETITE封面

APPETITE

学科领域：医学
影响因子：3.8
中科院分区： 2区
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA封面

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

学科领域：医学
影响因子：3.1
中科院分区： 2区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
3区
CELL BIOLOGY 细胞生物学
3区
PATHOLOGY 病理学
2区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
2区
PATHOLOGY 病理学
2区
CELL BIOLOGY 细胞生物学
3区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学2区
CELL BIOLOGY 细胞生物学
2区
PATHOLOGY 病理学
2区
ONCOLOGY 肿瘤学
3区
否
否